Last reviewed · How we verify
Donor specific antibodies — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Donor specific antibodies (Donor specific antibodies) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Donor specific antibodies TARGET | Donor specific antibodies | Assistance Publique - Hôpitaux de Paris | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Donor specific antibodies CI watch — RSS
- Donor specific antibodies CI watch — Atom
- Donor specific antibodies CI watch — JSON
- Donor specific antibodies alone — RSS
Cite this brief
Drug Landscape (2026). Donor specific antibodies — Competitive Intelligence Brief. https://druglandscape.com/ci/donor-specific-antibodies. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing